| Published Application/Species/Sample/Dilution | Reference |
|---|
- flow cytometry; human; 1:200; loading ...; fig 2d
| Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher |
- flow cytometry; human; loading ...; fig 1a
| Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher |
- flow cytometry; human; loading ...; fig 4a
| Bull C, Collado Camps E, Kers Rebel E, Heise T, Søndergaard J, den Brok M, et al. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. Immunol Cell Biol. 2017;95:408-415 pubmed publisher |
| Bendall S, Simonds E, Qiu P, Amir E, Krutzik P, Finck R, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science. 2011;332:687-96 pubmed publisher |
| Wu X, Wang A, Zhang S, Wang X, Guo D, Zhu W, et al. Multiomic landscape of immune pathogenesis in Kimura's disease. iScience. 2023;26:106559 pubmed publisher |
| Grivas A, Grigoriou M, Malissovas N, Sentis G, Filia A, Flouda S, et al. Combined - whole blood and skin fibroblasts- transcriptomic analysis in Psoriatic Arthritis reveals molecular signatures of activity, resistance and early response to treatment. Front Immunol. 2022;13:964274 pubmed publisher |
| Kenney D, O Connell A, Turcinovic J, Montanaro P, Hekman R, Tamura T, et al. Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection. Cell Rep. 2022;39:110714 pubmed publisher |
| Vanuytsel K, Villacorta Martin C, Lindstrom Vautrin J, Wang Z, Garcia Beltran W, Vrbanac V, et al. Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment. Nat Commun. 2022;13:1103 pubmed publisher |
| Galán Díez M, Borot F, Ali A, Zhao J, Gil Iturbe E, Shan X, et al. Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia. Cancer Discov. 2022;12:1106-1127 pubmed publisher |
| Zhu Z, Tang N, Wang M, Zhou J, Wang J, Ren H, et al. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. Front Immunol. 2021;12:781087 pubmed publisher |
| Cossarizza A, Chang H, Radbruch A, Abrignani S, Addo R, Akdis M, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur J Immunol. 2021;51:2708-3145 pubmed publisher |
| Han A, Lee J, Lee M, Ko S, Shin H, Lee J, et al. Distinct Repopulation Activity in Hu-Mice Between CB- and LPB-CD34＋ Cells by Enrichment of Transcription Factors. Int J Stem Cells. 2021;14:203-211 pubmed publisher |
| Bhattacherjee A, Jung J, Zia S, Ho M, Eskandari Sedighi G, St Laurent C, et al. The CD33 short isoform is a gain-of-function variant that enhances Aβ1-42 phagocytosis in microglia. Mol Neurodegener. 2021;16:19 pubmed publisher |
| Tcheng M, Roma A, Ahmed N, Smith R, Jayanth P, Minden M, et al. Very long chain fatty acid metabolism is required in acute myeloid leukemia. Blood. 2021;137:3518-3532 pubmed publisher |
| Lin G, Zhang Y, Yu L, Wu D. Cytotoxic effect of CLL‑1 CAR‑T cell immunotherapy with PD‑1 silencing on relapsed/refractory acute myeloid leukemia. Mol Med Rep. 2021;23: pubmed publisher |
| Schmiderer L, Subramaniam A, Žemaitis K, Bäckström A, Yudovich D, Soboleva S, et al. Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws. Proc Natl Acad Sci U S A. 2020;117:21267-21273 pubmed publisher |
| Subramaniam A, Žemaitis K, Safaee Talkhoncheh M, Yudovich D, Bäckström A, Debnath S, et al. Lysine-specific demethylase 1A (LSD1) restricts ex vivo propagation of human HSCs and is a target of UM171. Blood. 2020;: pubmed publisher |
| Salik B, Yi H, Hassan N, Santiappillai N, Vick B, Connerty P, et al. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia. Cancer Cell. 2020;: pubmed publisher |
| Zhao Y, Lu F, Ye J, Ji M, Pang Y, Wang Y, et al. Myeloid-Derived Suppressor Cells and γδT17 Cells Contribute to the Development of Gastric MALT Lymphoma in H. felis-Infected Mice. Front Immunol. 2019;10:3104 pubmed publisher |
| Chou D, Frismantas V, Milton Y, David R, Pop Damkov P, Ferguson D, et al. On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Nat Biomed Eng. 2020;4:394-406 pubmed publisher |
| Abd Hamid M, Colin York H, Khalid Alham N, Browne M, Cerundolo L, Chen J, et al. Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses. Cancer Immunol Res. 2020;8:203-216 pubmed publisher |
| Szentkereszty M, Komlósi Z, Szucs G, Barna G, Tamási L, Losonczy G, et al. Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer. Pathol Oncol Res. 2019;: pubmed publisher |
| Blaszczak A, Jalilvand A, Liu J, Wright V, Suzo A, Needleman B, et al. Human Visceral Adipose Tissue Macrophages Are Not Adequately Defined by Standard Methods of Characterization. J Diabetes Res. 2019;2019:8124563 pubmed publisher |
| Eriksson E, Milenova I, Wenthe J, Moreno R, Alemany R, Loskog A. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1. J Immunol. 2019;: pubmed publisher |
| Asada S, Goyama S, Inoue D, Shikata S, Takeda R, Fukushima T, et al. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Nat Commun. 2018;9:2733 pubmed publisher |
| Sade Feldman M, Kanterman J, Klieger Y, Ish Shalom E, Olga M, Saragovi A, et al. Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab. Clin Cancer Res. 2016;22:5661-5672 pubmed |
